Innovative Stem Cell Approach Offers Relief for Hirschsprung Disease

▴ Innovative Stem Cell Approach Offers Relief for Hirschsprung Disease
The research signifies a pivotal step forward in regenerative medicine, offering a glimmer of hope for those suffering from this debilitating condition.


Hirschsprung disease is a rare congenital condition affecting about 1 in 5000 babies. It is caused by the absence of nerve cells in the large intestine, which prevents the intestine from properly contracting and moving stool, leading to blockages, severe constipation, and potentially life-threatening infections like enterocolitis. Traditionally, the condition is treated with surgery soon after birth, but many patients continue to experience lifelong complications and often require multiple surgeries.


Researchers from the Universities of Sheffield and UCL have been exploring an innovative approach to treat Hirschsprung disease using stem cell therapy. Their study, recently published in Gut and funded by the Medical Research Council, offers promising results that could revolutionize treatment options for this condition.

The approach involves generating nerve cell precursors from stem cells and transplanting them into the gut tissue of patients with Hirschsprung disease. These precursors develop into the missing nerve cells, potentially restoring the intestine’s ability to contract and transport stool properly.


The research began in 2017 and is a collaborative effort between the University of Sheffield and UCL. The Sheffield team focused on producing and analyzing the nerve precursors from stem cells, while the UCL team prepared the patient gut tissue, performed the transplantations, and tested the functionality of the treated tissue segments.

Tissue samples were obtained from patients at Great Ormond Street Hospital (GOSH) as part of their routine treatment. These samples were cultured in the lab and then transplanted with the stem cell-derived nerve cell precursors. The transplanted gut tissues exhibited increased contraction ability compared to the control tissues, indicating improved functionality.


Dr. Conor McCann, Principal Investigator at the UCL Great Ormond Street Institute of Child Health, described the study as a significant breakthrough in cell therapy for Hirschsprung disease. "This study demonstrates the benefits of collaborative expertise and has the potential to benefit children and adults with Hirschsprung disease in the future," he said.

Dr. Anestis Tsakiridis, Principal Investigator at the University of Sheffield, highlighted the importance of this collaboration. He noted that the findings lay the groundwork for developing a cell therapy for Hirschsprung disease, with hopes of bringing it to clinical use in the coming years.


This study is the first to show the potential of stem cell therapy in improving the intestinal functionality of those with Hirschsprung disease. If successful in clinical applications, it could lead to better symptom management and overall outcomes for patients.

The research signifies a pivotal step forward in regenerative medicine, offering a glimmer of hope for those suffering from this debilitating condition. The ongoing efforts by scientists at Sheffield and UCL may soon turn this promising therapy into a viable treatment option, improving the quality of life for countless individuals affected by Hirschsprung disease.

Tags : #stem-cell #hirschsprung #birth #babies #enterocolitis

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026